The Potential Effect of Honey-derived D-Allulose in Counteracting Hyperglycemia by Time and Dose Dependent Manner in Diabetes Mellitus
Abstract
Diabetes mellitus has become a worldwide burden due to its persistent, chronic hyperglycemia. D-allulose, a monosaccharide sugar with a 180.16 molecular weight, is widely used as a low-calorie sweetener, is not involved in glucose-related metabolism, and thus does not alter insulin and pancreatic function. This study aimed to evaluate the potential role of honey-derived D-allulose in acute and sub-chronic diabetes mellitus. Diabetic Sprague-Dawley rats were divided into 9 groups and treated with 0.1, 0.2, and 0.4 g/kg BW honey-derived D-allulose for 28, 56, and 84 days. Post-prandial blood glucose levels and body weight were measured every 4 weeks. Significant reductions in post-prandial blood glucose levels were observed on days 56 and 84 treatment with 0.1 g/kg BW D-allulose. More significant reductions were observed on days 28, 56, and 84 of treatment with 0.2 or 0.4 g/kg BW D-allulose. Eighty-four days of treatment with 0.4 g/kg BW D-allulose significantly reduced post-prandial blood glucose levels compared to all groups. We identified that honey-derived D-allulose reduced post-prandial blood glucose levels in a dose- and time-dependent manner. Thus, honey-derived D-allulose may provide beneficial support for diabetic conditions not only as a sweetener but also as a pharmacological treatment.
Keywords
References
Cloete L. Diabetes mellitus: an overview of the types, symptoms, complications and management. Nursing standard (Royal College of Nursing (Great Britain). 2022; 37(1):61–66. https://doi.org/10.7748/ns.2021.e11709
Melmer A, Laimer M. Treatment Goals in Diabetes. Endocrine development. 2016;31:1–27. https://doi.org/10.1159/000439364
Chan HC, Zhu Y, Hu Y, et al. Crystal structures of D-psicose 3-epimerase from Clostridium cellulolyticum H10 and its complex with ketohexose sugars. Protein & cell. 2012:3(2):123–131. https://doi.org/10.1007/s13238-012-2026-5
Maeng HJ, Yoon JH, Chun KH, et al. Metabolic Stability of D-allulose in Biorelevant Media and Hepatocytes : Comparison with Fructose and Erythritol. Foods. 2019;8(10):448.
Jiang S, Xiao W, Zhu X, et al. Review on D-Allulose: In vivo Metabolism, Catalytic Mechanism, Engineering Strain Construction, Bio-Production Technology. Frontiers in bioengineering and biotechnology. 2020;8:26. https://doi.org/10.3389/fbioe.2020.00026
Zhang WL, Yu SH, Zhang T, et al. Recent advances in D-allulose: physiological functionalities, applications, and biological production. Trends in food science & technology. 2016;54:127–137.
1016/j.tifs.2016.06.004
Chattopadhyay S, Raychaudhuri U, Chakraborty R. Artificial sweeteners - a review. Journal of food science and technology. 2014;51(4):611–621.
Kishida K, Martinez G, Iida T, et al. d-Allulose is a substrate of glucose transporter type 5 (GLUT5) in the small intestine. Food chemistry. 2019;277:604–608. https://doi.org/10.1016/j.foodchem.2018.11.003
Matsuo T, Suzuki H, Hashiguchi M, et al. D-Psicose is a rare sugar that provides no energy to growing rats. Journal of nutritional science and vitaminology. 2002;48(1):77-80.
Van Laar ADE, Grootaert C, Van Camp J. Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?. Critical reviews in food science and nutrition. 2021;61(5):713–741. https://doi.org/10.1080/10408398.2020.1743966
Iwasaki Y, Sendo M, Dezaki, K, et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nature communications. 2018;9(1):113. https://doi.org/10.1038/s41467-017-02488-y
Whistler RL, Singh PP, Lake WC. D-Psicose metabolism in the rat. Carbohydrate research. 1974;34(1):200–202. https://doi.org/10.1016/s0008-6215(00)80385-7
Mooradian AD. In search for an alternative to sugar to reduce obesity. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. 2019;89(3-4):113–117. https://doi.org/10.1024/0300-9831/a000531
Daniel H, Hauner H, Hornef M, et al. Allulose in human diet: the knowns and the unknowns. The British journal of nutrition. 2022;128(2):172–178. https://doi.org/10.1017/S0007114521003172
Matsuo T, Izumori K. D-Psicose inhibits intestinal α-glucosidase and suppresses glycemic response after carbohydrate ingestion in rats. Kagawa Daigaku Nogakubu Gakujutsu Hokoku. 2006;111:27-32.
Iida T, Kishimoto Y, Yoshikawa Y, et al. Acute D-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. Journal of nutritional science and vitaminology. 2008;54(6), 511–514. https://doi.org/10.3177/jnsv.54.511
Haas MJ, Parekh S, Kalidas P, et al. Insulin mimetic effect of D-allulose on apolipoprotein A-I gene. Journal of food biochemistry. 2022;46(2):e14064. https://doi.org/10.1111/jfbc.14064
Lee D, Han Y, Kwon EY, et al. d-allulose Ameliorates Metabolic Dysfunction in C57BL/KsJ-db/db Mice. Molecules (Basel, Switzerland). 2020;25(16):3656. https://doi.org/10.3390/molecules25163656
Niibo M, Kanasaki A, Iida T, et al. d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes. PloS one. 2022;17(1):e0263300. https://doi.org/10.1371/journal.pone.0263300
Noronha JC, Braunstein CR, Glenn AJ, et al. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial. Diabetes, obesity & metabolism. 2018;20(10):2361–2370. https://doi.org/10.1111/dom.13374
Lee HY, Lee GH, Hoang TH, et al. d-Allulose Ameliorates Hyperglycemia Through IRE1α Sulfonation-RIDD-Sirt1 Decay Axis in the Skeletal Muscle. Antioxidants & redox signaling. 2022;37(4-6):229–245. https://doi.org/10.1089/ars.2021.0207
Soetikno V, Sari FR, Sukumaran V, et al. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2012;47(3):604–614. https://doi.org/10.1016/j.ejps.2012.04.018
Han Y, Han HJ, Kim AH, et al. d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition. Molecular nutrition & food research. 2016;60(7):1695–1706. https://doi.org/10.1002/mnfr.201500771
Tak J, Bok M, Rho H, et al. Effect of diabetes-specific oral nutritional supplements with allulose on weight and glycemic profiles in overweight or obese type 2 diabetic patients. Nutrition research and practice. 2023;17(2):241–256. https://doi.org/10.4162/nrp.2023.17.2.241
Hossain A, Yamaguchi F, Matsuo T, et al. Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus. Pharmacology & therapeutics. 2015;155:49–59. https://doi.org/10.1016/j.pharmthera.2015.08.004
Gou Y, Liu B, Cheng M, et al. d-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats. Molecules (Basel, Switzerland). 2021;26(20):6310. https://doi.org/10.3390/molecules26206310
Kim H, Park C, Sa S, et al. A study of D-allulose-associated reproductive toxicity in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019;131:110548. https://doi.org/10.1016/j.fct.2019.05.056
Teysseire F, Bordier V, Budzinska A, et al. Metabolic effects and safety aspects of acute D-allulose and erythritol administration in healthy subjects. Nutrients. 2023;15(2):458.
DOI: 10.15408/jkv.v9i2.34881
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Flori R. Sari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
